Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Non-GAAP total revenues by Year
Non-GAAP total revenues (historical through FY2021, $M) ($M)
Vertex Pharmaceuticals Non-GAAP total revenues: $7,573M in FY2021, up 22.1% from a year earlier. No newer figure appears in the documents we track.
Where the FY2021 figure comes from
“|| Non-GAAP total revenues | $ | 2,072.6 | $ | 1,626.9 | $ | 7,573.4 | $ | 6,202.8”
Source: Form 8-K (ex-991_q42021.htm, filed 2022-01-26) ↗
Reported in Form 8-K EX-99.1 Earnings Releases (FY2016–FY2021).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP total revenues (historical through FY2021, $M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2021 | Dec 31, 2021 | 7,573 | +22.1% | Form 8-K (ex-991_q42021.htm, filed 2022-01-26) ↗ |
| FY2020 | Dec 31, 2020 | 6,203 | +54.8% | Form 8-K (ex-991_q42021.htm, filed 2022-01-26) ↗ |
| FY2019 | Dec 31, 2019 | 4,007 | +31.7% | Form 8-K (ex-991_q42020.htm, filed 2021-02-01) ↗ |
| FY2018 | Dec 31, 2018 | 3,043 | +40.0% | Form 8-K (ex-991q42019.htm, filed 2020-01-30) ↗ |
| FY2017 | Dec 31, 2017 | 2,174 | +27.8% | Form 8-K (ex-991_q42018.htm, filed 2019-02-05) ↗ |
| FY2016 | Dec 31, 2016 | 1,701 | – | Form 8-K (ex-991_q42017.htm, filed 2018-01-31) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Non-GAAP total revenues ($M), annual FY2016–FY2021 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/nongaap-rev
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.